NextCell Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023
July 27, 2023 at 01:30 am EDT
NextCell Pharma AB reported earnings results for the third quarter and nine months ended May 31, 2023. For the third quarter, the company reported sales was SEK 3.04 million compared to SEK 1.61 million a year ago. Revenue was SEK 4.19 million compared to SEK 1.64 million a year ago. Net loss was SEK 10.92 million compared to SEK 9.31 million a year ago. Basic loss per share from continuing operations was SEK 0.32 compared to SEK 0.27 a year ago.
For the nine months, sales was SEK 7.28 million compared to SEK 4.23 million a year ago. Revenue was SEK 9.94 million compared to SEK 4.82 million a year ago. Net loss was SEK 31.24 million compared to SEK 25.99 million a year ago. Basic loss per share from continuing operations was SEK 0.91 compared to SEK 0.76 a year ago.